{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:11:55Z","timestamp":1773299515618,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect Reporting System. The results of the examination of population scale data revealed that patients who received ketamine had significantly lower frequency of reports of depression than patients who took any other combination of drugs for pain. The analysis also revealed that patients who took ketamine had significantly lower frequency of reports of pain and opioid induced side effects, implying ketamine\u2019s potential to act as a beneficial adjunct agent in pain management pharmacotherapy. Further, the Inverse-Frequency Analysis methodology provides robust statistical support for the antidepressant action of other currently approved therapeutics including diclofenac and minocycline.<\/jats:p>","DOI":"10.1038\/s41598-017-01590-x","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T11:23:08Z","timestamp":1493292188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications"],"prefix":"10.1038","volume":"7","author":[{"given":"Isaac V.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tigran","family":"Makunts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Atayee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Abagyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1126\/science.274.5288.740","volume":"274","author":"CJ Murray","year":"1996","unstructured":"Murray, C. J. & Lopez, A. D. Evidence-based health policy\u2013lessons from the Global Burden of Disease Study. Science \n                           274, 740\u2013743, doi:10.1126\/science.274.5288.740 (1996).","journal-title":"Science"},{"key":"1590_CR2","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA \n                           289, 3095\u20133105, doi:10.1001\/jama.289.23.3095 (2003).","journal-title":"JAMA"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1741-7015-9-90","volume":"9","author":"E Bromet","year":"2011","unstructured":"Bromet, E. et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med \n                           9, 90, doi:10.1186\/1741-7015-9-90 (2011).","journal-title":"BMC Med"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mpr.138","volume":"12","author":"L Andrade","year":"2003","unstructured":"Andrade, L. et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res \n                           12, 3\u201321, doi:10.1002\/(ISSN)1557-0657 (2003).","journal-title":"Int J Methods Psychiatr Res"},{"key":"1590_CR5","first-page":"41","volume":"9","author":"RA Sansone","year":"2012","unstructured":"Sansone, R. A. & Sansone, L. A. Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci \n                           9, 41\u201346 (2012).","journal-title":"Innov Clin Neurosci"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","volume":"7","author":"A Frazer","year":"2002","unstructured":"Frazer, A. & Benmansour, S. Delayed pharmacological effects of antidepressants. Mol Psychiatry \n                           7, S23\u201328, doi:10.1038\/sj.mp.4001015 (2002). Suppl 1.","journal-title":"Mol Psychiatry"},{"key":"1590_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000442293","volume":"85","author":"C Braun","year":"2016","unstructured":"Braun, C., Bschor, T., Franklin, J. & Baethge, C. Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder. Psychother Psychosom \n                           85, 171\u2013179, doi:10.1159\/000442293 (2016).","journal-title":"Psychother Psychosom"},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S1461145708009139","volume":"12","author":"F Seem\u00fcller","year":"2009","unstructured":"Seem\u00fcller, F. et al. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. Int J Neuropsychopharmacol \n                           12, 181\u2013189, doi:10.1017\/S1461145708009139 (2009).","journal-title":"Int J Neuropsychopharmacol"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry \n                           163, 1905\u20131917, doi:10.1176\/ajp.2006.163.11.1905 (2006).","journal-title":"Am J Psychiatry"},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/da.22253","volume":"31","author":"RB Price","year":"2014","unstructured":"Price, R. B. et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety \n                           31, 335\u2013343, doi:10.1002\/da.22253 (2014).","journal-title":"Depress Anxiety"},{"key":"1590_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","volume":"71","author":"N DiazGranados","year":"2010","unstructured":"DiazGranados, N. et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry \n                           71, 1605\u20131611, doi:10.4088\/JCP.09m05327blu (2010).","journal-title":"J Clin Psychiatry"},{"key":"1590_CR12","unstructured":"Alberich, S. et al. Efficacy and safety of ketamine in bipolar depression: A systematic review. Rev Psiquiatr Salud Ment (2016)."},{"key":"1590_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1017\/S1461145711000629","volume":"14","author":"GL Larkin","year":"2011","unstructured":"Larkin, G. L. & Beautrais, A. L. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol \n                           14, 1127\u20131131, doi:10.1017\/S1461145711000629 (2011).","journal-title":"Int J Neuropsychopharmacol"},{"key":"1590_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pnpbp.2012.02.002","volume":"37","author":"T Miyaoka","year":"2012","unstructured":"Miyaoka, T. et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry \n                           37, 222\u2013226, doi:10.1016\/j.pnpbp.2012.02.002 (2012).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.12373","volume":"18","author":"JD Rosenblat","year":"2016","unstructured":"Rosenblat, J. D. et al. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord \n                           18, 89\u2013101, doi:10.1111\/bdi.2016.18.issue-2 (2016).","journal-title":"Bipolar Disord"},{"key":"1590_CR16","unstructured":"FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm082193.htm (Accessed 2016)."},{"key":"1590_CR17","unstructured":"The Adverse Event Reporting System (AERS): Older Quarterly Data Files. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm083765.htm (Accessed 2016)."},{"key":"1590_CR18","unstructured":"Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS) http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/default.htm (Acessed 2016)."}],"updated-by":[{"DOI":"10.1038\/s41598-017-14992-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01590-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:04:00Z","timestamp":1671768240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01590-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"assertion":[{"value":"21 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML version of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1450"}}